7^th  –  9^th of June, Amsterdam, Netherlands  

Ulf Landegren, cofounder of the PLA technology and part of the board of directors for Navinci, will speak on June 7th; his talk has the title Dual-recognition Protein Assays.

Our CEO Robert Gunnarsson will also attend the meeting. 

7^th – 8^th of June, Berlin, Germany
Meet us in booth 14; Jeanette Axelsson (CBO), Ida Hansson (Scientific Sales specialist), Lena Beckman (Marketing Manager), and Axel Klaesson (Senior scientist) will be there. They are eager to talk to you about next-generation in situ methods and how to bring precision to spatial proteomics.

Ulf Landegren, cofounder of the PLA technology and part of the board of directors for Navinci, will speak on June 8th; his talk has the title Tools For In Situ Detection Of Nucleic Acids & Proteins.

20^rd – 23^rd of June, Seville, Spain 

We will go to EACR 2022 with some exciting news! Visit us at booth 54 for the newest information about protein-protein interaction assays in cancer research.  

Navinci will be represented by; Agata Wicher (CSO), Jeanette Axelsson (CBO), Ida Hansson (Scientific Sales Specialist), and Desireé Edén (Scientist and project lead). 

10^th -12^th of May, AstraZeneca, Gothenburg, Sweden 

Jeanette Axelsson (CBO) and Ida Hansson (Scientific sales specialist) will represent Navinci. Interested in talking about Proximity Ligation Assay in cell-based screening? Please reach out to them!

8^th – 13^th of April, New Orleans, Louisiana, US.

Lena Beckman (Marketing Manager) and Desireé Edén will represent Navinci at AACR 2022; if you are interested in knowing more about Proximity Ligation Assay in cancer research, please reach out to them.